Scarica l'app Stockscreener
13.99
2.72%
0.37
Dopo l'orario di chiusura:
14.33
0.34
+2.43%
Precedente Chiudi:
$13.62
Aprire:
$14.07
Volume 24 ore:
49,129
Relative Volume:
1.76
Capitalizzazione di mercato:
$28.64M
Reddito:
-
Utile/perdita netta:
$-4.85M
Rapporto P/E:
-45.13
EPS:
-0.31
Flusso di cassa netto:
$-3.95M
1 W Prestazione:
+3.40%
1M Prestazione:
+6.39%
6M Prestazione:
-6.73%
1 anno Prestazione:
+3.63%
Intervallo 1D:
$13.91
$14.50
Intervallo di 1 settimana:
$13.48
$14.50
Portata 52W:
$8.74
$22.90
Cadrenal Therapeutics Inc Stock (CVKD) Company Profile
Nome
Cadrenal Therapeutics Inc
Settore
Industria
Telefono
904-300-0701
Indirizzo
822 A1A NORTH, PONTE VEDRA
Confronta CVKD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVKD
Cadrenal Therapeutics Inc
|
13.99 | 27.88M | 0 | -4.85M | -3.95M | -0.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cadrenal Therapeutics Inc Stock (CVKD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-12-18 | Iniziato | Noble Capital Markets | Outperform |
Cadrenal Therapeutics Inc Borsa (CVKD) Ultime notizie
What institutional flow reveals about Cadrenal Therapeutics Inc.2025 Market Outlook & Long Hold Capital Preservation Tips - newser.com
Is Cadrenal Therapeutics Inc a good long term investmentProtective Put Strategies & Unlock Long-Term Capital Growth Ideas - earlytimes.in
Applying chart zones and confluence areas to Cadrenal Therapeutics Inc.2025 Buyback Activity & Entry Point Confirmation Alerts - newser.com
Published on: 2025-10-13 02:03:23 - newser.com
How to escape a deep drawdown in Cadrenal Therapeutics Inc.July 2025 Retail & Free High Return Stock Watch Alerts - newser.com
Can Cadrenal Therapeutics Inc. recover in the next quarterMarket Performance Summary & Accurate Intraday Trading Signals - newser.com
What does recent volatility data suggest for Cadrenal Therapeutics Inc.Earnings Risk Report & Consistent Return Strategy Ideas - newser.com
Visual trend scoring systems applied to Cadrenal Therapeutics Inc.Long Setup & Weekly Setup with ROI Potential - newser.com
Cadrenal Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 Update & Expert Curated Trade Ideas - newser.com
Backtesting results for Cadrenal Therapeutics Inc. trading strategiesBreakout Watch & Real-Time Chart Pattern Alerts - newser.com
Custom watchlist performance reports with Cadrenal Therapeutics Inc.2025 Price Momentum & Consistent Income Trade Ideas - newser.com
Cadrenal therapeutics CFO Szot sells $1496 in shares - Investing.com
Cadrenal Therapeutics Inc. stock daily chart insightsWeekly Volume Report & Community Shared Stock Ideas - newser.com
Can Cadrenal Therapeutics Inc. stock beat market expectations this quarterSwing Trade & Free Expert Verified Stock Movement Alerts - newser.com
Can Cadrenal Therapeutics Inc. stock sustain institutional interestMarket Trend Report & Risk Adjusted Buy/Sell Alerts - newser.com
Cadrenal Therapeutics Expands Pipeline With Portfolio Acquisition Worth Up To $15 Million - MSN
Insider Sell: Matthew Szot Sells Shares of Cadrenal Therapeutics Inc (CVKD) - GuruFocus
CVKD: Acquires Factor XIa Inhibitors - Smartkarma
CVKD: Acquires Factor XIa Inhibitors… - Yahoo Finance
Will a bounce in Cadrenal Therapeutics Inc. offer an exitWeekly Investment Recap & Consistent Return Investment Signals - newser.com
Cadrenal Therapeutics Inc Stock Analysis and ForecastVolume Analysis Techniques & Hidden Gems with Outstanding Profit Margins - earlytimes.in
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025 - GlobeNewswire
Anticoagulation Therapy Biotech Cadrenal Therapeutics to Showcase Pipeline at Lytham Investor Conference - Stock Titan
Published on: 2025-09-30 10:26:28 - earlytimes.in
Multi factor analysis applied to Cadrenal Therapeutics Inc.2025 Support & Resistance & Daily Profit Maximizing Trade Tips - newser.com
What analysts say about Cadrenal Therapeutics Inc stockLow Beta Stocks & High Return Trading Ideas - earlytimes.in
Cadrenal therapeutics (CVKD) CEO Pham sells $131,779 in stock By Investing.com - Investing.com Australia
Cadrenal Therapeutics Inc Azioni (CVKD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):